| 标题 |
982P Osimertinib (osi) + savolitinib (savo) in EGFR-mutated (EGFRm) advanced non-small cell lung cancer (NSCLC) with MET overexpression and/or amplification (OverExp/Amp) following progressive disease (PD) on osi: SAVANNAH Asian subset |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:S-H. Lee; T.M. Kim; I. Okamoto; J. Shimizu; Y-H. Luo; et al 出版日期:2025 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)